DioKronic Medisys

India
Diagnostic products and services in blood banking and healthcare.

About DioKronic Medisys

DioKronic Medisys is a Healthcare company based in India. Diagnostic products and services in blood banking and healthcare. Its Indian entity Diokronic Medisys Private Limited reported revenue of β‚Ή8.07 Cr. DioKronic Medisys offers products and services including Hematology Analyzer and Maglumi 800. Its focus areas include Life Sciences, Pathology Equipment, Diagnostic Solutions and Diagnostics.

Company details

Diokronic Medisys is identified as an Indian diagnostic company that was established in 2019 to distribute and develop products for domestic and international markets. It is recognized for offering innovative solutions in blood banking, healthcare diagnostics, pathology equipment, and life sciences, with a focus on meeting customer needs through partnerships. The company maintains values such as integrity and excellence, aiming to provide quality solutions at affordable prices while exceeding client expectations in product supply and support. Awards like the Outstanding Performer from Tarsons Plastics have been received for its contributions.

  • Headquarters India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website diokronic.com
  • Legal Name Diokronic Medisys Pvt. Ltd
  • Date of Incorporation 25 Feb, 2019
  • Jurisdiction Lucknow, Uttar Pradesh, India
Key Metrics
  • Annual Revenue
    ₹8.07 Cr

    FY 2024 · +5% YoY

  • Net Profit
    ₹14.8 Lakh

    FY 2024 · 2% margin

  • EBITDA
    ₹24.7 Lakh

    FY 2024 · 3% margin

Products & Services of DioKronic Medisys

DioKronic Medisys offers a comprehensive portfolio of products and services, including Hematology Analyzer and Maglumi 800.

Hematology Analyzer
Diagnostic Equipment

This product is utilized for analyzing blood samples in healthcare settings.

Maglumi 800
Chemiluminescence Immunoassay

This service is provided for diagnostic testing in pathology and life sciences.

Board of directors of Diokronic Medisys Private Limited (DioKronic Medisys)

Diokronic Medisys Private Limited is the primary company behind DioKronic Medisys. The board of Diokronic Medisys Private Limited currently have 3 directors; the longest-serving is Adarsh Ranjan Trivedi, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Adarsh Ranjan Trivedi
DIN 08373548
Director25 Feb 20197 yrs 8 moDiokronic Medisys Private Limited
Neelu Trivedi
DIN 08373549
Director25 Feb 20197 yrs 8 moDiokronic Medisys Private Limited
Priti Tewari
DIN 03371839
Director25 Feb 20197 yrs 8 moDiokronic Medisys Private Limited

Financials of DioKronic Medisys

Figures of Diokronic Medisys Private Limited, the primary company behind DioKronic Medisys, for FY 2024. Revenue was ₹8.07 Cr (+5% year on year). Net profit was ₹14.8 Lakh (2% margin). EBITDA was ₹24.7 Lakh (3% margin). Revenue has grown at a compounded annual rate of -33% over three years.

  • ₹8.07 CrRevenue · FY 2024 · +5% YoY
  • ₹14.8 LakhNet profit · 2% margin
  • ₹24.7 LakhEBITDA · 3% margin
  • ₹21.5 LakhPaid-up capital
  • -33%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Diokronic Medisys Private Limited are on its company page.

Premium access

Detailed financial statements for DioKronic Medisys

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Diagnostics Laboratories

3 companies that operate in the same segment as DioKronic Medisys (Diagnostics Laboratories) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Diagnostic testing centers for pathology and health screenings are operated.
1996Mumbai, Maharashtra, IndiaUSD 63.59 MUSD 90.17 M1,979
Chain of pathology and radiology labs
1949Gurugram, Haryana, IndiaUSD 13.9 MUSD 294.49 M5,310
Home-based diagnostic tests are booked via an online platform.
2018Noida, Uttar Pradesh, IndiaUSD 116.42 MUSD 52.45 M2,334
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about DioKronic Medisys

DioKronic Medisys is headquartered in India.

The primary company behind DioKronic Medisys, Diokronic Medisys Private Limited, reported revenue of β‚Ή8.07 Cr for FY 2024, up 5% year on year.

Diokronic Medisys is identified as an Indian diagnostic company that was established in 2019 to distribute and develop products for domestic and international markets. It is recognized for offering innovative solutions in blood banking, healthcare diagnostics, pathology equipment, and life sciences, with a focus on meeting customer needs through partnerships. The company maintains values such as integrity and excellence, aiming to provide quality solutions at affordable prices while exceeding client expectations in product supply and support. Awards like the Outstanding Performer from Tarsons Plastics have been received for its contributions.

DioKronic Medisys offers Hematology Analyzer and Maglumi 800.

DioKronic Medisys operates through Diokronic Medisys Private Limited.

The legal entities of DioKronic Medisys currently have 3 directors, including Adarsh Ranjan Trivedi, Neelu Trivedi, Priti Tewari.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available